The opinions expressed by columnists are their own and do not represent our advertisers

Tuesday, March 31, 2015

New hepatitis C drugs cost Medicare billions

Medicare spent $4.5 billion last year on new, pricey medications that cure the liver disease hepatitis C — more than 15 times what it spent the year before on older treatments for the disease, previously undisclosed federal data shows.

The extraordinary outlays for these breakthrough drugs, which can cost $1,000 a day or more, will be borne largely by federal taxpayers, who pay for most of Medicare’s prescription drug program. But the expenditures will also mean higher deductibles and maximum out-of-pocket costs for many of the program’s 39 million seniors and disabled enrollees, who pay a smaller share of its cost, experts and federal officials said.


1 comment:

Anonymous said...

You can buy it in other countries for next to nothing. Our tax dollars funded the trials through NIH...AND KUDOS TO THEM FOR FINDING A CURE. Point is, we need to make drugs in development for life threatening illness more readily available and get the breakthrough drugs in the hands of the people who need them. Our health care system is more broken than ever.